Spyre Therapeutics, Inc. ($SYRE)
Filing Information
| Accession Number | 0001636282-26-000087 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 3, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
25,002
Total Value
$959,747.20
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Jul 1, 2026 | Exercise/Conversion | 8,334 | $27.46 | $228,851.64 | 8,334 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jul 1, 2026 | Sale | 6,500 | $87.52 | $568,880.00 | 1,834 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jul 1, 2026 | Sale | 1,834 | $88.34 | $162,015.56 | 0 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (Right to Buy) | Derivative | Jul 1, 2026 | Exercise/Conversion | 8,334 | $0.00 | $0.00 | 305,000 | Direct | โ | View Details |